Clinical Trial Update: Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating tarlatamab for extensive-stage small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Tarlatamab

Snippet

Sponsor: Asrar Alahmadi | Conditions: Extensive Stage Lung Small Cell Carcinoma | Phase 2 | Status: RECRUITING